Yang, W., Hsu, C., Hsu, T., Liou, J., Chang, K., Chen, P., . . . Chuang, J. (2020). Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma. Neuro Oncol.
استشهاد بنمط شيكاغوYang, Wen-Bin, et al. "Increased Activation of HDAC1/2/6 and Sp1 Underlies Therapeutic Resistance and Tumor Growth in Glioblastoma." Neuro Oncol 2020.
MLA استشهادYang, Wen-Bin, et al. "Increased Activation of HDAC1/2/6 and Sp1 Underlies Therapeutic Resistance and Tumor Growth in Glioblastoma." Neuro Oncol 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.